With most brokers taking a well-earned break over the holiday period, broker notes are few and far between right now.
But don't worry, listed below are a few recent recommendations that remain very relevant today. Here's what brokers are saying about these ASX shares:
CSL Limited (ASX: CSL)
According to a note out of Citi, its analysts have retained their buy rating and $325.00 price target on this biotechnology giant's shares. The broker highlights that it has been at rival Takeda's Plasma-Derived Therapies investor event and left feeling very positive about the outlook for immunoglobulin growth over the medium term despite competition from FcRns. In light of this, the broker remains confident in its growth forecasts for CSL's immunoglobulin business. The CSL share price is trading at $285.81 this afternoon.
Lovisa Holdings Ltd (ASX: LOV)
A note out of Morgans reveals that its analysts have retained their add rating and $27.50 price target on this fashion jewellery retailer's shares. The broker remains very positive on Lovisa following a review of the retail sector after recent updates at annual general meetings. In fact, following the review, Morgans has named it as one of its key picks in the sector. The Lovisa share price is fetching $24.60 on Friday.
Origin Energy Ltd (ASX: ORG)
Analysts at Macquarie have retained their outperform rating and $9.26 price target on this energy company's shares. This follows news that Origin has made another investment in the Octopus business. While the broker acknowledges that the investment will be cash flow negative in the near term, it doesn't believe Origin's dividends will suffer because of this. For example, Macquarie has pencilled in a 62 cents per share dividend this year and next, which implies yields greater than 7%. The Origin share price is trading at $8.38 on Friday.
